Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZ

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Huagai , Sichuan , China , Boston , Massachusetts , United States , San Diego , California , Suzhou , Jiangsu , Hong Kong , Australia , Wuxi , Singapore , Beijing , Menlo Park , Shanghai , Chinese , Lerna Biopharma , Zhuhai Biotheus , Trinity Innovation Fund , Astrazeneca , China Phase , Wuxi Apptec , Wuxi Biologics , Senti Biosciences , Huagai Capital , Trinity Innovation , Porton Advanced , Large Language Models , Adeno Associated Virus , Growing Pains , Boston Scientific , Liver Meeting ,